Prevention & lipids

Unsupervised Learning-Derived Complex Metabolic Signatures Refine Cardiometabolic Risk

JACC AdvPublished Phenome-wide and genome-wide association studies, prospective cohort analyses and Mendelian randomization

Authors' conclusion

These metabolic signatures extract comprehensive information from the metabolomic profile while maintaining clarity and interpretability, facilitating clinical translation. The findings emphasize the crucial roles of lipid subpopulations in cardiometabolic risks, encouraging clinicians to take a more nuanced approach to managing blood lipids and balancing different disease risks.

Study context

Population
UK Biobank participants with plasma metabolomic profiles
Participants
118,001 UK Biobank participants
Exposure
Unsupervised learning-derived metabolic signatures vs traditional lipids in cardiometabolic risk prediction
Outcome
Metabolic clusters identified
Methodological detailsunsupervised learning, nuclear magnetic resonance metabolomics
  • Unsupervised learning
  • Nuclear magnetic resonance metabolomics

Main finding

As reported in the abstract

Metabolic clusters
Eleven
Linked loci
101
Linked phenotypes, mostly cardiometabolic diseases
445

Observational data: associations, not effects.

Further findings

Cardiometabolic risk prediction

Novel signatures partially outperformed traditional lipids
Triglyceride-rich lipoproteins superior predictive power for ischemic heart disease, type 2 diabetes, and hypertension compared with apolipoprotein B and lipoprotein(a)

Non-high-density lipoprotein cholesterol and cardiometabolic diseases

Increased risk of hyperlipidemia and ischemic heart disease; protective effect against type 2 diabetes

High-density lipoprotein clusters and cardiometabolic diseases

Subpopulations enriched in free cholesterol or triglyceride increasing risk
Subpopulations enriched in cholesterol esters providing protection
  • Heterogeneous associations

Original publication

Unsupervised Learning-Derived Complex Metabolic Signatures Refine Cardiometabolic Risk. JACC Adv. Published 20 February 2025. doi:10.1016/j.jacadv.2025.101620

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.